{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:12:46Z","timestamp":1775567566070,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1038\/nm1213","type":"journal-article","created":{"date-parts":[[2005,4,6]],"date-time":"2005-04-06T13:21:32Z","timestamp":1112793692000},"page":"S45-S53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1300,"title":["Mucosal immunity and vaccines"],"prefix":"10.1038","volume":"11","author":[{"given":"Jan","family":"Holmgren","sequence":"first","affiliation":[]},{"given":"Cecil","family":"Czerkinsky","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2005,4,5]]},"reference":[{"key":"BFnm1213_CR1","volume-title":"Mucosal Immunology","author":"J Mestecky","year":"2005","unstructured":"Mestecky, J. et al. (eds). Mucosal Immunology 3rd edn. (Academic Press, San Diego, 2005)."},{"key":"BFnm1213_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nri1057","volume":"3","author":"AM Mowat","year":"2003","unstructured":"Mowat, A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3, 331\u2013341 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm1213_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nri1439","volume":"4","author":"H Kiyono","year":"2004","unstructured":"Kiyono, H. & Fukuyama, S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat. Rev. Immunol. 4, 699\u2013710 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm1213_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF02790407","volume":"20","author":"H Ishikawa","year":"1999","unstructured":"Ishikawa, H., Saito, H., Suzuki, K., Oida, T. & Kanamori, Y. New gut associated lymphoid tissue \u201ccryptopatches\u201d breed murine intestinal intraepithelial T cell precursors. Immunol. Res. 20, 243\u2013250 (1999).","journal-title":"Immunol. Res."},{"key":"BFnm1213_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1084\/jem.20021639","volume":"197","author":"D Guy-Grand","year":"2003","unstructured":"Guy-Grand, D. et al. Extrathymic T cell lymphopoiesis: ontogeny and contribution to gut intraepithelial lymphocytes in athymic and euthymic mice. J. Exp. Med. 197, 333\u2013341 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnm1213_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1053\/j.gastro.2004.01.028","volume":"127","author":"J Bilsborough","year":"2004","unstructured":"Bilsborough, J. & Viney, J.L. Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease. Gastroenterology 127, 300\u2013309 (2004).","journal-title":"Gastroenterology"},{"key":"BFnm1213_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1084\/jem.190.2.229","volume":"190","author":"A Iwasaki","year":"1999","unstructured":"Iwasaki, A. & Kelsall, B.L. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190, 229\u2013239 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnm1213_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","volume":"118","author":"S Rakoff-Nahoum","year":"2004","unstructured":"Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229\u2013241 (2004).","journal-title":"Cell"},{"key":"BFnm1213_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nri1203","volume":"3","author":"EJ Kunkel","year":"2003","unstructured":"Kunkel, E.J. & Butcher, E.C. Plasma-cell homing. Nat. Rev. Immunol. 3, 822\u2013829 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm1213_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.smim.2003.08.005","volume":"15","author":"DJ Campbell","year":"2003","unstructured":"Campbell, D.J., Debes, G.F., Johnston, B., Wilson, E. & Butcher, E.C. Targeting T cell responses by selective chemokine receptor expression. Semin. Immunol. 15, 277\u2013286 (2003).","journal-title":"Semin. Immunol."},{"key":"BFnm1213_CR11","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E","volume":"32","author":"AJ Stagg","year":"2002","unstructured":"Stagg, A.J., Kamm, M.A. & Knight, S.C. Intestinal dendritic cells increase T cell expression of \u03b14\u03b27 integrin. Eur. J. Immunol. 32, 1445\u20131454 (2002).","journal-title":"Eur. J. Immunol."},{"key":"BFnm1213_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature01726","volume":"424","author":"JR Mora","year":"2003","unstructured":"Mora, J.R. et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424, 88\u201393 (2003).","journal-title":"Nature"},{"key":"BFnm1213_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","volume":"21","author":"M Iwata","year":"2004","unstructured":"Iwata, M. et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21, 527\u2013538 (2004).","journal-title":"Immunity"},{"key":"BFnm1213_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1172\/JCI115270","volume":"88","author":"M Quiding","year":"1991","unstructured":"Quiding, M. et al. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses, gamma-interferon production, and evokes local immunological memory. J. Clin. Invest. 88, 143\u2013148 (1991).","journal-title":"J. Clin. Invest."},{"key":"BFnm1213_CR15","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1128\/IAI.66.12.5889-5896.1998","volume":"66","author":"K Eriksson","year":"1998","unstructured":"Eriksson, K. et al. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infect. Immun. 66, 5889\u20135896 (1998).","journal-title":"Infect. Immun."},{"key":"BFnm1213_CR16","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1128\/iai.65.4.1387-1394.1997","volume":"65","author":"PA Kozlowski","year":"1997","unstructured":"Kozlowski, P.A., Cu-Uvin, S., Neutra, M.R. & Flanigan, T.P. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect. Immun. 65, 1387\u20131394 (1997).","journal-title":"Infect. Immun."},{"key":"BFnm1213_CR17","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1128\/IAI.69.6.4125-4128.2001","volume":"69","author":"M Jertborn","year":"2001","unstructured":"Jertborn, M., Nordstr\u00f6m, I., Kilander, A., Czerkinsky, C. & Holmgren, J. Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans. Infect. Immun. 69, 4125\u20134128 (2001).","journal-title":"Infect. Immun."},{"key":"BFnm1213_CR18","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.vaccine.2003.09.002","volume":"22","author":"EL Johansson","year":"2004","unstructured":"Johansson, E.L., Bergquist, C., Edebo, A., Johansson, C. & Svennerholm, A.-M. Comparison of different routes of vaccination for eliciting antibody responses in the human stomach. Vaccine 22, 984\u2013990 (2004).","journal-title":"Vaccine"},{"key":"BFnm1213_CR19","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.1128\/IAI.69.12.7481-7486.2001","volume":"69","author":"E-L Johansson","year":"2001","unstructured":"Johansson, E.-L., Wass\u00e9n, L., Holmgren, J., Jertborn, M. & Rudin, A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect. Immun. 69, 7481\u20137486 (2001).","journal-title":"Infect. Immun."},{"key":"BFnm1213_CR20","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/jnci\/djg018","volume":"95","author":"D Nardelli-Haefliger","year":"2003","unstructured":"Nardelli-Haefliger, D. et al. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J. Natl. Cancer Inst. 95, 1128\u20131137 (2003).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFnm1213_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0161-5890(00)00074-2","volume":"37","author":"CM Gockel","year":"2000","unstructured":"Gockel, C.M., Bao, S. & Beagley, K.W. Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract. Mol. Immunol. 37, 537\u2013544 (2000).","journal-title":"Mol. Immunol."},{"key":"BFnm1213_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00005176-200405000-00001","volume":"38","author":"Q Yuan","year":"2004","unstructured":"Yuan, Q. & Walker, W.A. Innate immunity of the gut: mucosal defense in health and disease. J. Pediatr. Gastroenterol. Nutr. 38, 463\u2013473 (2004).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFnm1213_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-3083.1987.tb02208.x","volume":"25","author":"N Lycke","year":"1987","unstructured":"Lycke, N., Eriksen, L. & Holmgren, J. Protection against cholera toxin after oral immunization is thymus-dependent and associated with intestinal production of neutralizing IgA antitoxin. Scand. J. Immunol. 25, 413\u2013419 (1987).","journal-title":"Scand. J. Immunol."},{"key":"BFnm1213_CR24","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.4049\/jimmunol.155.6.2877","volume":"155","author":"CE Hornquist","year":"1995","unstructured":"Hornquist, C.E., Ekman, L., Grdic, K.D., Schon, K. & Lycke, N.Y. Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation. J. Immunol. 155, 2877\u20132887 (1995).","journal-title":"J. Immunol."},{"key":"BFnm1213_CR25","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1126\/science.288.5474.2222","volume":"288","author":"AJ Macpherson","year":"2000","unstructured":"Macpherson, A.J. et al. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288, 2222\u20132226 (2000).","journal-title":"Science"},{"key":"BFnm1213_CR26","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.4049\/jimmunol.174.2.1046","volume":"174","author":"M Stoel","year":"2005","unstructured":"Stoel, M. et al. Restricted IgA repertoire in both B-1 and B-2 cell-derived gut plasmablasts. J. Immunol. 174, 1046\u20131054 (2005).","journal-title":"J. Immunol."},{"key":"BFnm1213_CR27","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1006\/cyto.1998.0385","volume":"10","author":"ME Goodrich","year":"1998","unstructured":"Goodrich, M.E. & McGee, D.W. Regulation of mucosal B cell immunoglobulin secretion by intestinal epithelial cell-derived cytokines. Cytokine 10, 948\u2013955 (1998).","journal-title":"Cytokine"},{"key":"BFnm1213_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2249.2004.02440.x","volume":"136","author":"T Asano","year":"2004","unstructured":"Asano, T. et al. Molecular analysis of B cell differentiation in selective or partial IgA defiency. Clin. Exp. Immunol. 136, 284\u2013290 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnm1213_CR29","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.4049\/jimmunol.157.6.2521","volume":"157","author":"LS Klavinskis","year":"1996","unstructured":"Klavinskis, L.S. et al. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes. J. Immunol. 157, 2521\u20132527 (1996).","journal-title":"J. Immunol."},{"key":"BFnm1213_CR30","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.4049\/jimmunol.167.9.5386","volume":"167","author":"HF Staats","year":"2001","unstructured":"Staats, H.F. et al. Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization. J. Immunol. 167, 5386\u20135394 (2001).","journal-title":"J. Immunol."},{"key":"BFnm1213_CR31","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1172\/JCI20261","volume":"113","author":"IM Belyakov","year":"2004","unstructured":"Belyakov, I.M., Hammond, S.A., Ahlers, J.D., Glenn, G.M. & Berzofsky, J.A. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J. Clin. Invest. 113, 998\u20131007 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnm1213_CR32","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1128\/jvi.69.12.7800-7806.1995","volume":"69","author":"MA Franco","year":"1995","unstructured":"Franco, M.A. & Greenberg, H.B. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J. Virol. 69, 7800\u20137806 (1995).","journal-title":"J. Virol."},{"key":"BFnm1213_CR33","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1084\/jem.175.4.1143","volume":"175","author":"BS Bender","year":"1992","unstructured":"Bender, B.S., Croghan, T., Zhang, L. & Small, P.A. Jr. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J. Exp. Med. 175, 1143\u20131145 (1992).","journal-title":"J. Exp. Med."},{"key":"BFnm1213_CR34","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.4049\/jimmunol.158.12.5883","volume":"158","author":"D Buzoni-Gatel","year":"1997","unstructured":"Buzoni-Gatel, D., Lepage, A.C., Dimier-Poisson, I.H., Bout, D.T. & Kasper, L.H. Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii. J. Immunol. 158, 5883\u20135889 (1997).","journal-title":"J. Immunol."},{"key":"BFnm1213_CR35","first-page":"338","volume":"81","author":"JC Bowen","year":"1994","unstructured":"Bowen, J.C., Nair, S.K., Reddy, R. & Rouse, B.T. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens. Immunology 81, 338\u2013342 (1994).","journal-title":"Immunology"},{"key":"BFnm1213_CR36","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.4049\/jimmunol.166.2.1106","volume":"166","author":"CP Simmons","year":"2001","unstructured":"Simmons, C.P. et al. Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses. J. Immunol. 166, 1106\u20131113 (2001).","journal-title":"J. Immunol."},{"key":"BFnm1213_CR37","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/iai.65.3.1032-1044.1997","volume":"65","author":"M Johansson","year":"1997","unstructured":"Johansson, M., Sch\u00f6n, K., Ward, M. & Lycke, N. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect. Immun. 65, 1032\u20131044 (1997).","journal-title":"Infect. Immun."},{"key":"BFnm1213_CR38","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1084\/jem.188.12.2277","volume":"188","author":"TH Ermak","year":"1998","unstructured":"Ermak, T.H. et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188, 2277\u20132288 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnm1213_CR39","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.1128\/JVI.75.14.6705-6709.2001","volume":"75","author":"AM Harandi","year":"2001","unstructured":"Harandi, A.M., Svennerholm, B., Holmgren, J. & Eriksson, K. Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity. J. Virol. 75, 6705\u20136709 (2001).","journal-title":"J. Virol."},{"key":"BFnm1213_CR40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1385\/IR:28:3:265","volume":"28","author":"HY Wu","year":"2003","unstructured":"Wu, H.Y. & Weiner, H.L. Oral tolerance. Immunol. Res. 28, 265\u2013284 (2003).","journal-title":"Immunol. Res."},{"key":"BFnm1213_CR41","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4049\/jimmunol.147.7.2155","volume":"147","author":"CC Whitacre","year":"1991","unstructured":"Whitacre, C.C., Gienapp, I.E., Orosz, C.G. & Bitar, D.M. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol. 147, 2155\u20132163 (1991).","journal-title":"J. Immunol."},{"key":"BFnm1213_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/376177a0","volume":"376","author":"Y Chen","year":"1995","unstructured":"Chen, Y. et al. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376, 177\u2013180 (1995).","journal-title":"Nature"},{"key":"BFnm1213_CR43","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4049\/jimmunol.120.3.861","volume":"120","author":"J Ngan","year":"1978","unstructured":"Ngan, J. & Kind, L.S. Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. J. Immunol. 120, 861\u2013865 (1978).","journal-title":"J. Immunol."},{"key":"BFnm1213_CR44","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1006\/jaut.1997.0148","volume":"10","author":"M Polanski","year":"1997","unstructured":"Polanski, M., Melican, N.S., Zhang, J. & Weiner, H.L. Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines. J. Autoimmun. 10, 339\u2013346 (1997).","journal-title":"J. Autoimmun."},{"key":"BFnm1213_CR45","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/39614","volume":"389","author":"H Groux","year":"1997","unstructured":"Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737\u2013742 (1997).","journal-title":"Nature"},{"key":"BFnm1213_CR46","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7520605","volume":"265","author":"Y Chen","year":"1994","unstructured":"Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A. & Weiner, H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237\u20131240 (1994).","journal-title":"Science"},{"key":"BFnm1213_CR47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.188.2.287","volume":"188","author":"AM Thornton","year":"1998","unstructured":"Thornton, A.M. & Shevach, E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287\u2013296 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnm1213_CR48","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151\u20131164 (1995).","journal-title":"J. Immunol."},{"key":"BFnm1213_CR49","doi-asserted-by":"publisher","first-page":"8886","DOI":"10.1073\/pnas.1533365100","volume":"100","author":"L Klein","year":"2003","unstructured":"Klein, L., Khazaie, K. & von Boehmer, H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl Acad. Sci. USA 100, 8886\u20138891 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnm1213_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1084\/jem.20030315","volume":"198","author":"LS Walker","year":"2003","unstructured":"Walker, L.S., Chodos, A., Eggena, M., Dooms, H. & Abbas, A.K. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 198, 249\u2013258 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnm1213_CR51","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/eji.200324656","volume":"34","author":"M Stassen","year":"2004","unstructured":"Stassen, M. et al. Human CD25+ regulatory T cells: two subsets defined by the integrins \u03b14\u03b27 or \u03b14\u03b21 confer distinct suppressive properties upon CD4+ T helper cells. Eur. J. Immunol. 34, 1303\u20131311 (2004).","journal-title":"Eur. J. Immunol."},{"key":"BFnm1213_CR52","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","volume":"21","author":"CT Huang","year":"2004","unstructured":"Huang, C.T. et al. Role of LAG-3 in regulatory T cells. Immunity 21, 503\u2013513 (2004).","journal-title":"Immunity"},{"key":"BFnm1213_CR53","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1126\/science.7916481","volume":"265","author":"C McMenamin","year":"1994","unstructured":"McMenamin, C., Pimm, C., McKersey, M. & Holt, P.G. Regulation of IgE responses to inhaled antigen in mice by antigen-specific \u03b3\u03b4 T cells. Science 265, 1869\u20131871 (1994).","journal-title":"Science"},{"key":"BFnm1213_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1034\/j.1600-065X.2000.917303.x","volume":"173","author":"A Hanninen","year":"2000","unstructured":"Hanninen, A. & Harrison, L.C. \u03b3\u03b4 T cells as mediators of mucosal tolerance: the autoimmune diabetes model. Immunol. Rev. 173, 109\u2013119 (2000).","journal-title":"Immunol. Rev."},{"key":"BFnm1213_CR55","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri981","volume":"3","author":"IN Crispe","year":"2003","unstructured":"Crispe, I.N. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3, 51\u201362 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm1213_CR56","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.4049\/jimmunol.173.2.1043","volume":"173","author":"K Roelofs-Haarhuis","year":"2004","unstructured":"Roelofs-Haarhuis, K., Wu, X. & Gleichmann, E. Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J. Immunol. 173, 1043\u20131050 (2004).","journal-title":"J. Immunol."},{"key":"BFnm1213_CR57","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/90667","volume":"2","author":"O Akbari","year":"2001","unstructured":"Akbari, O., DeKruyff, R.H. & Umetsu, D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2, 725\u2013731 (2001).","journal-title":"Nat. Immunol."},{"key":"BFnm1213_CR58","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/infdis\/158.1.160","volume":"158","author":"G Zhaori","year":"1988","unstructured":"Zhaori, G., Sun, M. & Ogra, P.L. Characteristics of the immune response to poliovirus virion polypeptides after immunization with live or inactivated polio vaccines. J. Infect. Dis. 158, 160\u2013165 (1988).","journal-title":"J. Infect. Dis."},{"key":"BFnm1213_CR59","unstructured":"World Health Organization. Cholera vaccines. WHO position paper. Wkly. Epidemiol. Rec. 76, 117\u2013124 (2001)."},{"key":"BFnm1213_CR60","first-page":"499","volume-title":"New Generation Vaccines","author":"J Holmgren","year":"2004","unstructured":"Holmgren, J. & Bergquist, C. Oral B subunit killed whole-cell cholera vaccines. in New Generation Vaccines 3rd edn. (ed. Levine, M.M. et al.) 499\u2013510 (Marcel Dekker, New York, 2004)."},{"key":"BFnm1213_CR61","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJMoa043323","volume":"352","author":"M Lucas","year":"2005","unstructured":"Lucas, M. et al. High-level effectiveness of a mass oral cholera vaccination in Beira, Mozambique. N. Engl. J. Med. 352, 757\u2013767 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1213_CR62","unstructured":"Ali, M. et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh. Lancet (in the press)."},{"key":"BFnm1213_CR63","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","volume":"349","author":"DD Trach","year":"1997","unstructured":"Trach, D.D. et al. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Lancet 349, 231\u2013235 (1997).","journal-title":"Lancet"},{"key":"BFnm1213_CR64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0020-2452(96)85758-7","volume":"93","author":"MM Levine","year":"1995","unstructured":"Levine, M.M. & Kaper, J.B. Live oral cholera vaccine: from principle to product. Bull. Inst. Pasteur 93, 243\u2013253 (1995).","journal-title":"Bull. Inst. Pasteur"},{"key":"BFnm1213_CR65","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","volume":"18","author":"E Richie","year":"2000","unstructured":"Richie, E. et al. Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine 18, 2399\u20132410 (2000).","journal-title":"Vaccine"},{"key":"BFnm1213_CR66","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","volume":"317","author":"IL Acharya","year":"1987","unstructured":"Acharya, I.L. et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N. Engl. J. Med. 317, 1101\u20131104 (1987).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1213_CR67","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0264-410X(95)00186-5","volume":"14","author":"K Klugman","year":"1996","unstructured":"Klugman, K. et al. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 14, 435\u2013438 (1996).","journal-title":"Vaccine"},{"key":"BFnm1213_CR68","first-page":"625","volume":"79","author":"HH Yang","year":"2001","unstructured":"Yang, H.H. et al. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in Southwestern China. Bull. World Health Organ. 79, 625\u2013631 (2001).","journal-title":"Bull. World Health Organ."},{"key":"BFnm1213_CR69","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","volume":"17","author":"MM Levine","year":"1999","unstructured":"Levine, M.M. et al. Duration of efficacy of Ty21a attenuated Salmonella typhi live oral vaccine. Vaccine 17, S22\u2013S27 (1999).","journal-title":"Vaccine"},{"key":"BFnm1213_CR70","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bpg.2003.11.004","volume":"18","author":"AM Svennerholm","year":"2004","unstructured":"Svennerholm, A.M. & Steele, D. Microbial-gut interactions in health and disease. Progress in enteric vaccine development. Best Pract. Res. Clin. Gastroenterol. 18, 421\u2013445 (2004).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"BFnm1213_CR71","doi-asserted-by":"publisher","first-page":"S179","DOI":"10.1097\/01.inf.0000142370.16514.4a","volume":"23","author":"B De Vos","year":"2004","unstructured":"De Vos, B. et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 23, S179\u2013S182 (2004).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"BFnm1213_CR72","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1586\/14760584.3.6.643","volume":"3","author":"R Belshe","year":"2004","unstructured":"Belshe, R., Lee, M.-S., Walker, R.E., Stoddard, J. & Mendelman, P.M. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Rev. Vaccines 3, 643\u2013654 (2004).","journal-title":"Expert Rev. Vaccines"},{"key":"BFnm1213_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","volume":"59","author":"RJ Cox","year":"2004","unstructured":"Cox, R.J., Brokstad, K.A. & Ogra, P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand. J. Immunol. 59, 1\u201315 (2004).","journal-title":"Scand. J. Immunol."},{"key":"BFnm1213_CR74","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(00)02579-4","volume":"356","author":"L Chaillous","year":"2000","unstructured":"Chaillous, L. et al. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Lancet 356, 545\u2013549 (2000).","journal-title":"Lancet"},{"key":"BFnm1213_CR75","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2165\/00063030-200216030-00003","volume":"16","author":"H Wiendl","year":"2002","unstructured":"Wiendl, H. & Hohlfeld, R. Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials. BioDrugs 16, 183\u2013200 (2002).","journal-title":"BioDrugs"},{"key":"BFnm1213_CR76","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11926-001-0052-z","volume":"3","author":"AE Postlethwaite","year":"2001","unstructured":"Postlethwaite, A.E. Can we induce tolerance in rheumatoid arthritis? Curr. Rheumatol. Rep. 3, 64\u201369 (2001).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnm1213_CR77","doi-asserted-by":"publisher","first-page":"7196","DOI":"10.1073\/pnas.93.14.7196","volume":"93","author":"JB Sun","year":"1996","unstructured":"Sun, J.B., Rask, C., Olsson, T., Holmgren, J. & Czerkinsky, C. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl Acad. Sci. USA 93, 7196\u20137201 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnm1213_CR78","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1073\/pnas.94.9.4610","volume":"94","author":"I Bergerot","year":"1997","unstructured":"Bergerot, I. et al. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl Acad. Sci. USA 94, 4610\u20134614 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnm1213_CR79","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/1529-0131(199908)42:8<1628::AID-ANR10>3.0.CO;2-T","volume":"42","author":"A Tarkowski","year":"1999","unstructured":"Tarkowski, A., Sun, J.-B., Holmdahl, R., Holmgren, J. & Czerkinsky, C. Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine. Arthritis Rheum. 42, 1628\u20131634 (1999).","journal-title":"Arthritis Rheum."},{"key":"BFnm1213_CR80","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/immu.200390025","volume":"33","author":"PA Phipps","year":"2003","unstructured":"Phipps, P.A. et al. Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit. Eur. J. Immunol. 33, 224\u2013232 (2003).","journal-title":"Eur. J. Immunol."},{"key":"BFnm1213_CR81","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0264-410X(96)00135-1","volume":"15","author":"S Tamura","year":"1997","unstructured":"Tamura, S., Hatori, E., Tsuruhara, T., Aizawa, C. & Kurata, T. Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin. Vaccine 15, 225\u2013229 (1997).","journal-title":"Vaccine"},{"key":"BFnm1213_CR82","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2249.2004.02520.x","volume":"137","author":"M Stanford","year":"2004","unstructured":"Stanford, M. et al. Oral tolerization with peptide 336\u2013351 linked to cholera toxin B subunit preventing relapses of uveitis in Behcet's disease. Clin. Exp. Immunol. 137, 201\u2013208 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnm1213_CR83","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1398-9995.2005.00699.x","volume":"60","author":"DR Wilson","year":"2005","unstructured":"Wilson, D.R., Torres Lima, M. & Dirham, S.R. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60, 4\u201312 (2005).","journal-title":"Allergy"},{"key":"BFnm1213_CR84","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1046\/j.1365-2222.2003.01587.x","volume":"33","author":"V Di Rienzo","year":"2003","unstructured":"Di Rienzo, V. et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin. Exp. Allergy 33, 206\u2013210 (2003).","journal-title":"Clin. Exp. Allergy"},{"key":"BFnm1213_CR85","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2165\/00128071-200405050-00001","volume":"5","author":"F Mastrandrea","year":"2004","unstructured":"Mastrandrea, F. The potential role of allergen-specific sublingual immunotherapy in atopic dermatitis. Am. J. Clin. Dermatol. 5, 281\u2013294 (2004).","journal-title":"Am. J. Clin. Dermatol."},{"key":"BFnm1213_CR86","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ymeth.2003.08.016","volume":"32","author":"S Vrtala","year":"2004","unstructured":"Vrtala, S., Focke-Tejkl, M., Swoboda, I., Kraft, D. & Valenta, R. Strategies for converting allergens into hypoallergenic vaccine candidates. Methods 32, 313\u2013320 (2004).","journal-title":"Methods"},{"key":"BFnm1213_CR87","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1016\/S0264-410X(03)00206-8","volume":"21","author":"J Holmgren","year":"2003","unstructured":"Holmgren, J., Czerkinsky, C., Eriksson, K. & Harandi, A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 21, S89\u2013S95 (2003).","journal-title":"Vaccine"},{"key":"BFnm1213_CR88","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ijmm.2004.03.001","volume":"294","author":"C Schoen","year":"2004","unstructured":"Schoen, C., Stritzker, J., Goebel, W. & Pilgrim, S. Bacteria as DNA vaccine carriers for genetic immunization. Int. J. Med. Microbiol. 294, 319\u2013335 (2004).","journal-title":"Int. J. Med. Microbiol."},{"key":"BFnm1213_CR89","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1440-1711.2004.01288.x","volume":"82","author":"M Vajdy","year":"2004","unstructured":"Vajdy, M. et al. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines. Immunol. Cell Biol. 82, 617\u2013627 (2004).","journal-title":"Immunol. Cell Biol."},{"key":"BFnm1213_CR90","doi-asserted-by":"publisher","first-page":"10139","DOI":"10.1128\/JVI.75.21.10139-10148.2001","volume":"75","author":"W Shi","year":"2001","unstructured":"Shi, W., Liu, J., Huang, Y. & Qiao, L. Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T lymphocyte responses. J. Virol. 75, 10139\u201310148 (2001).","journal-title":"J. Virol."},{"key":"BFnm1213_CR91","doi-asserted-by":"publisher","first-page":"9713","DOI":"10.1128\/JVI.75.20.9713-9722.2001","volume":"75","author":"RA Guerrero","year":"2001","unstructured":"Guerrero, R.A. et al. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J. Virol. 75, 9713\u20139722 (2001).","journal-title":"J. Virol."},{"key":"BFnm1213_CR92","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/viro.2001.1240","volume":"293","author":"M Niikura","year":"2002","unstructured":"Niikura, M. et al. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes. Virology 293, 273\u2013280 (2002).","journal-title":"Virology"},{"key":"BFnm1213_CR93","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1586\/14760584.2.2.205","volume":"2","author":"J Holmgren","year":"2003","unstructured":"Holmgren, J., Harandi, A.M. & Czerkinsky, C. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Expert Rev. Vaccines 2, 205\u2013217 (2003).","journal-title":"Expert Rev. Vaccines"},{"key":"BFnm1213_CR94","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2174\/1568026043451230","volume":"4","author":"A Plant","year":"2004","unstructured":"Plant, A. & Williams, N.A. Modulation of the immune response by the cholera-like enterotoxins. Curr. Top. Med. Chem. 4, 509\u2013519 (2004).","journal-title":"Curr. Top. Med. Chem."},{"key":"BFnm1213_CR95","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/S0264-410X(00)00553-3","volume":"19","author":"M Pizza","year":"2001","unstructured":"Pizza, M. et al. Mucosal vaccines: non-toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19, 2534\u20132541 (2001).","journal-title":"Vaccine"},{"key":"BFnm1213_CR96","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0264-410X(01)00452-2","volume":"20","author":"X Lu","year":"2002","unstructured":"Lu, X., Clements, J.D. & Katz, J.M. Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine. Vaccine 20, 1019\u20131029 (2002).","journal-title":"Vaccine"},{"key":"BFnm1213_CR97","doi-asserted-by":"publisher","first-page":"33369","DOI":"10.1074\/jbc.M112337200","volume":"277","author":"J Sanchez","year":"2002","unstructured":"Sanchez, J., Wallerstr\u00f6m, G., Fredriksson, M., Angstrom, J. & Holmgren, J. Detoxification of cholera toxin without removal of its immunoadjuvanticity by the addition of (STa-related) peptides to the catalytic subunit. A potential new strategy to generate immunostimulants for vaccination. J. Biol. Chem. 277, 33369\u201333377 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm1213_CR98","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.1462-5822.2003.00338.x","volume":"6","author":"N Lycke","year":"2004","unstructured":"Lycke, N. From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD\/ISCOM. Cell. Microbiol. 6, 23\u201332 (2004).","journal-title":"Cell. Microbiol."},{"key":"BFnm1213_CR99","first-page":"103","volume":"21","author":"MJ McCluskie","year":"2001","unstructured":"McCluskie, M.J., Weeratna, R.D., Payette, P.J. & Davis, H.L. The potential of CpG oligodeoxynucleotides as mucosal adjuvants. Crit. Rev. Immunol. 21, 103\u2013120 (2001).","journal-title":"Crit. Rev. Immunol."},{"key":"BFnm1213_CR100","first-page":"141","volume":"5","author":"AM Harandi","year":"2004","unstructured":"Harandi, A.M. & Holmgren, J. CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infections. Curr. Opin. Investig. Drugs 5, 141\u2013145 (2004).","journal-title":"Curr. Opin. Investig. Drugs"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm1213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1213","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:35:12Z","timestamp":1744371312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":100,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["BFnm1213"],"URL":"https:\/\/doi.org\/10.1038\/nm1213","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"5 April 2005","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}